Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study.

Gómez-Peralta F, Carramiñana-Barrera F, Félix-Redondo FJ, Fraile-Gómez J; Extreme Rescue Study Group.

Int J Clin Pract. 2012 Oct;66(10):959-68. doi: 10.1111/j.1742-1241.2012.03000.x.

PMID:
22994330
[PubMed - indexed for MEDLINE]
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007 Jun;29(6 Pt 1):1254-70. Review.

PMID:
18036388
[PubMed - indexed for MEDLINE]
4.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
[PubMed - indexed for MEDLINE]
5.

Premixed insulin analogues for the treatment of diabetes mellitus.

Garber AJ.

Drugs. 2006;66(1):31-49. Review.

PMID:
16398567
[PubMed - indexed for MEDLINE]
6.

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM, Marinopoulos SS, Ranasinghe P, Amer M, Bass EB.

Ann Intern Med. 2008 Oct 21;149(8):549-59. Epub 2008 Sep 15. Review.

PMID:
18794553
[PubMed - indexed for MEDLINE]
7.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

PMID:
20646668
[PubMed - indexed for MEDLINE]
Free Article
8.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007;29 Spec No:1254-70. Review.

PMID:
18046926
[PubMed - indexed for MEDLINE]
9.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
[PubMed - indexed for MEDLINE]
10.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
11.

Premixed insulin treatment for type 2 diabetes: analogue or human?

Garber AJ, Ligthelm R, Christiansen JS, Liebl A.

Diabetes Obes Metab. 2007 Sep;9(5):630-9. Review.

PMID:
17697056
[PubMed - indexed for MEDLINE]
12.

Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.

Vinik A.

Clin Ther. 2007;29 Spec No:1236-53. Review.

PMID:
18046925
[PubMed - indexed for MEDLINE]
13.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

PMID:
15525480
[PubMed - indexed for MEDLINE]
Free Article
14.

Methods to enhance delivery of prandial insulin and basal-prandial insulin.

Garber AJ.

Diabetes Obes Metab. 2013 Mar;15 Suppl 1:11-7. doi: 10.1111/dom.12067. Review.

PMID:
23448198
[PubMed - indexed for MEDLINE]
15.
16.

Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.

Owens DR.

Diabet Med. 2013 Mar;30(3):276-88. doi: 10.1111/dme.12019. Review.

PMID:
22998363
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease.

Hermansen K, Mortensen LS, Hermansen ML.

Vasc Health Risk Manag. 2008;4(3):561-74. Review.

PMID:
18827907
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.

Balena R, Hensley IE, Miller S, Barnett AH.

Diabetes Obes Metab. 2013 Jun;15(6):485-502. doi: 10.1111/dom.12025. Epub 2012 Nov 12. Review.

PMID:
23061470
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues.

Vaag A, Lund SS.

Eur J Endocrinol. 2012 Feb;166(2):159-70. doi: 10.1530/EJE-11-0022. Epub 2011 Sep 19. Review. Erratum in: Eur J Endocrinol. 2012 Mar;166(3):565. Lund, Sørens [corrected to Lund, Søren S].

PMID:
21930715
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Intensifying insulin therapy: what options are available to patients with type 2 diabetes?

Meneghini LF.

Am J Med. 2013 Sep;126(9 Suppl 1):S28-37. doi: 10.1016/j.amjmed.2013.06.011. Review.

PMID:
23953077
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk